title: Polyamine deprivation alters formalin-induced hyperalgesia and decreases morphine efficacy.
abstract: Although the exact functions of polyamines in the nervous system remain still unclear, they are thought to have a physiological role in intracellular signal processing and neurotransmission. Polyamine deprivation which consists in the reduction of both the endogenous and exogenous sources of polyamines is a promising treatment for cancer. In a previous study we have shown that this treatment provokes an analgesic effect in rats submitted to brief phasic nociceptive tests. The present study examined the effect of polyamine deprivation on pain-related behaviors and spinal c-fos expression evoked in the formalin test presumed to better reflect clinical pain, using morphine as analgesia control. Polyamine deprivation per se altered the characteristic pain-related behaviors, reducing the interphase depression of pain, without inducing changes in the spinal Fos staining. In addition this treatment prevented the antinociceptive effect of morphine both on behavioral responses and on spinal c-fos expression. In polyamine-deprived rats, despite morphine injection, nociceptive scores remained dramatically high during the intermediate and the late phases of the response and the number of Fos immunoreactive neurons remained largely higher in deeper layers than in morphine control rats. Altogether these data support a modulatory role of polyamines both on the neuronal circuitry mediating sensory information, and on mechanisms underlying morphine analgesia.
authors.affiliation: CNRS-ESA 6027, Groupe de Recherche en Thérapeutique AntiCancéreuse, Faculté de Médecine 2, Rennes, France.
authors.forename: S
authors.initials: S
authors.lastname: Kergozien
authors.forename: J G
authors.initials: JG
authors.lastname: Delcros
authors.forename: D
authors.initials: D
authors.lastname: Desury
authors.forename: J P
authors.initials: JP
authors.lastname: Moulinoux
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D015317:Biogenic Polyamines / Q000502:physiology*; D006930:Hyperalgesia / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D007150:Immunohistochemistry; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D010147:Pain Measurement; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis; D051381:Rats; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism
chemical_list: D000701:Analgesics, Opioid; D015317:Biogenic Polyamines; D016760:Proto-Oncogene Proteins c-fos; D009020:Morphine